Oxaprozin
Product Images NDC 66336-722

2 FDA label images from Dispensing Solutions, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Oxaprozin (NDC 66336-722). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Dispensing Solutions, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (9cc9adbe 0a51 41a6 8b42 A8b66f587c77 01)

Chemical Structure (9cc9adbe 0a51 41a6 8b42 A8b66f587c77 01)
Chemical structure of Oxaprozin, showing its molecular arrangement with a phenyl group, a furan ring, and a carboxylic acid moiety connected by an ethylene linker.*
FDA Label Image

Ndc 66336-0722-xx (Ndc 66336 0722 Xx Sandoz)

Ndc 66336-0722-xx (Ndc 66336 0722 Xx      Sandoz)
Oxaprozin 600 mg tablet label from Dispensing Solutions, Inc., indicating prescription-only status. The label includes dosage strength, NDC 66336-0722-XX, and quantity marked as XX tablets. It also warns to store at 68°-77°F, keep out of children's reach, and to dispense with medication guide. The label notes the tablets are white, capsule-shaped, film-coated, bisected, and debossed E141, with manufacturer Sandoz Inc., Princeton, NJ.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.